de Verneuil Vanina 4
4 · Vir Biotechnology, Inc. · Filed Nov 5, 2024
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP, General Counsel, Corp Sec
Transactions
- Sale
Common Stock
2024-11-05$9.47/sh−2,347$22,225→ 61,370 total - Sale
Common Stock
2024-11-01$7.20/sh−1,403$10,107→ 63,717 total
Footnotes (3)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.